Journal
ONCOTARGET
Volume 6, Issue 26, Pages 22028-22037Publisher
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.4314
Keywords
large cell lung cancer; LCNEC; mutation; gene fusion; ALK
Categories
Funding
- Swedish Cancer Society
- Knut & Alice Wallenberg Foundation
- Foundation for Strategic Research through the Lund Centre for Translational Cancer Research (CREATE Health)
- Mrs Berta Kamprad Foundation
- Gunnar Nilsson Cancer Foundation
- Swedish Research Council
- Lund University Hospital Research Funds
- Gustav V:s Jubilee Foundation
- govermnental funding (ALF)
Ask authors/readers for more resources
Large cell carcinoma with or without neuroendocrine features (LCNEC and LC, respectively) constitutes 3-9% of non-small cell lung cancer but is poorly characterized at the molecular level. Herein we analyzed 41 LC and 32 LCNEC (including 15 previously reported cases) tumors using massive parallel sequencing for mutations in 26 cancer-related genes and gene fusions in ALK, RET, and ROS1. LC patients were additionally subdivided into three immunohistochemistry groups based on positive expression of TTF-1/Napsin A (adenocarcinoma-like, n = 24; 59%), CK5/P40 (squamous-like, n = 5; 12%), or no marker expression (marker-negative, n = 12; 29%). Most common alterations were TP53 (83%), KRAS (22%), MET (12%) mutations in LCs, and TP53 (88%), STK11 (16%), and PTEN (13%) mutations in LCNECs. In general, LCs showed more oncogene mutations compared to LCNECs. Immunomarker stratification of LC revealed oncogene mutations in 63% of adenocarcinoma-like cases, but only in 17% of marker-negative cases. Moreover, marker-negative LCs were associated with inferior overall survival compared with adenocarcinoma-like tumors (p = 0.007). No ALK, RET or ROS1 fusions were detected in LCs or LCNECs. Together, our molecular analyses support that LC and LCNEC tumors follow different tumorigenic paths and that LC may be stratified into molecular subgroups with potential implications for diagnosis, prognostics, and therapy decisions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available